Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-06-020675
Filing Date
2006-03-30
Accepted
2006-03-30 13:42:33
Documents
1
Period of Report
2006-03-27

Document Format Files

Seq Description Document Type Size
1 rrd112785.html 4  
1 rrd112785.xml 4 2894
  Complete submission text file 0001181431-06-020675.txt   4673
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Issuer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 14100 SW 72ND AVE PORTLAND OR 97224
Business Address 118 OLD OX RD GHENT NY 12075
CASHEN ANTHONY B (Reporting) CIK: 0001084252 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12934 | Film No.: 06722142